Neurostimulation Devices Market (By Device Type: Implantable Devices and External Devices; By Application: Parkinson’s Disease, Pain Management, Epilepsy, Hearing Loss, Gastroparesis, Urinary And Fecal Incontinence, Depression, And Others; By Geography: North America, Europe, Asia-Pacific and Row) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024
Global Neurostimulation devices Market is estimated to reach $10.2 Billion by 2024; growing at a CAGR of 12.7% from 2016 to 2024.Neurostimulation devices provide electronic stimulation to specific nerves in the body. These devices are externally or operationally set in the patient’s body and functions are done by thin wires or leads. They provide control, reduces pain, and provide relaxation to various therapeutic conditions such as paralyzed patients, and others. Neurostimulation devices are extremely beneficial in reducing pain of neurological disorders including chronic pain, epilepsy, major depression, and parkinson's disease. Spinal cord stimulators, vagus nerve stimulators, sacral nerve stimulators, deep brain stimulators, and cortical stimulators are most commonly used devices. Increasing population and growing demand for neurostimulation devices in the healthcare sector are enhancing the growth of the market.
Technological advancements and increasing need for add-on services drives the growth of the global neurostimulation devices market. Rapid growth in population and high demand from healthcare sectors also supports the growth of the market. Moreover, product innovation and growing investments in R&D would provide several opportunities for the market. However, high cost may hinder the growth of the market.
The global neurostimulation devices market has been segmented as device type, application, and geography. Device type is bifurcated into implantable devices (spinal cord stimulation, sacral nerve stimulation, deep brain stimulation, cochlear implants, vagus nerve stimulation, gastric electric stimulation and others) and external devices (transcranial magnetic stimulation (TMS), transcutaneous electrical nerve stimulation (TENS), and others). By application, the segmentations are urinary and gastroparesis, fecal incontinence, pain management, epilepsy, parkinson’s disease, hearing loss, depression, and others.
By geography, the market has been bifurcated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers UK, Germany, France, and others. Asia-Pacific covers China, Japan, India, and others. RoW covers South America, Middle East, and Africa.
The major players in the market include Boston Scientific Corporation, Cyberonics, Inc., Neuropace, Inc., St. Jude Medical, Inc., BioControl Medical, DePuy Synthes Companies, Synapse Biomedical, Inc., Nevro Corporation, NDI Medical, LLC, and NeuroSigma, Inc., among others.
The key takeaways from the report
Device Type Segments
Technological advancements and increasing need for add-on services drives the growth of the global neurostimulation devices market. Rapid growth in population and high demand from healthcare sectors also supports the growth of the market. Moreover, product innovation and growing investments in R&D would provide several opportunities for the market. However, high cost may hinder the growth of the market.
The global neurostimulation devices market has been segmented as device type, application, and geography. Device type is bifurcated into implantable devices (spinal cord stimulation, sacral nerve stimulation, deep brain stimulation, cochlear implants, vagus nerve stimulation, gastric electric stimulation and others) and external devices (transcranial magnetic stimulation (TMS), transcutaneous electrical nerve stimulation (TENS), and others). By application, the segmentations are urinary and gastroparesis, fecal incontinence, pain management, epilepsy, parkinson’s disease, hearing loss, depression, and others.
By geography, the market has been bifurcated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers UK, Germany, France, and others. Asia-Pacific covers China, Japan, India, and others. RoW covers South America, Middle East, and Africa.
The major players in the market include Boston Scientific Corporation, Cyberonics, Inc., Neuropace, Inc., St. Jude Medical, Inc., BioControl Medical, DePuy Synthes Companies, Synapse Biomedical, Inc., Nevro Corporation, NDI Medical, LLC, and NeuroSigma, Inc., among others.
The key takeaways from the report
- The report will provide a detailed analysis of Global Neurostimulation Devices Market with respect to major segments such as device type, application, and geography
- The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024
- Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
- An exhaustive regional analysis of Global Neurostimulation Devices Market from 2015 to 2024 has been included in the report
- Profile of the key players in the Global Neurostimulation Devices Market will be provided, which include key financials, product & services, new developments and business strategies
Device Type Segments
- Implantable Devices
- Spinal Cord Stimulation
- Sacral Nerve Stimulation
- Deep Brain Stimulation
- Cochlear Implants
- Vagus Nerve Stimulation
- Gastric Electric Stimulation
- Others
- External Devices
- Transcranial Magnetic Stimulation (TMS)
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Others
- Urinary and Gastroparesis
- Fecal Incontinence
- Pain Management
- Epilepsy
- Parkinson’s Disease
- Hearing Loss
- Depression
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Others
- Asia Pacific
- China
- Japan
- India
- Others
- RoW
- South America
- Middle East
- Africa
CHAPTER 1 PREFIX
1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 In-house Data Modeling
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OUTLINE
3.1 Market Inclination, Trend, Outlook and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Value Chain Analysis
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Impact Analysis
3.4.2 Restraints
3.4.2.1 Impact Analysis
3.4.3 Opportunities
3.5 Porter’s five forces analysis
3.5.1 Factors Impact Analysis
CHAPTER 4 NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE: MARKET SIZE AND FORECAST, 2015 – 2024
4.1 Overview
4.2 Implantable Devices
4.2.1 Current Trend and Analysis
4.2.2 Market Size and Forecast
4.2.3 Cochlear Implants
4.2.4 Deep Brain Stimulation
4.2.5 Spinal Cord Stimulation
4.2.6 Vagus Nerve Stimulation
4.2.7 Sacral Nerve Stimulation
4.2.8 Gastric Electric Stimulation
4.2.9 Others
4.3 External Devices
4.3.1 Current Trend and Analysis
4.3.2 Market Size and Forecast
4.3.3 Transcranial Magnetic Stimulation (TMS)
4.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
4.3.5 Others
CHAPTER 5 NEUROSTIMULATION DEVICES MARKET BY APPLICATION: MARKET SIZE AND FORECAST, 2015 – 2024
5.1 Overview
5.2 Parkinson’s Disease
5.2.1 Current Trend and Analysis
5.2.2 Market Size and Forecast
5.3 Pain Management
5.3.1 Current Trend and Analysis
5.3.2 Market Size and Forecast
5.4 Epilepsy
5.4.1 Current Trend and Analysis
5.4.2 Market Size and Forecast
5.5 Hearing Loss
5.5.1 Current Trend and Analysis
5.5.2 Market Size and Forecast
5.6 Gastroparesis
5.6.1 Current Trend and Analysis
5.6.2 Market Size and Forecast
5.7 Urinary and Fecal Incontinence
5.7.1 Current Trend and Analysis
5.7.2 Market Size and Forecast
5.8 Depression
5.8.1 Current Trend and Analysis
5.8.2 Market Size and Forecast
5.9 Others
5.9.1 Current Trend and Analysis
5.9.2 Market Size and Forecast
CHAPTER 6 NEUROSTIMULATION DEVICES MARKET BY GEOGRAPHY: MARKET SIZE AND FORECAST, 2015 – 2024
6.1 Overview
6.2 North America
6.2.1 Current Trend and Analysis
6.2.2 Market Size and Forecast
6.2.3 U.S.
6.2.3.1 Market Size and Forecast
6.2.4 Canada
6.2.4.1 Market Size and Forecast
6.2.5 Mexico
6.2.5.1 Market Size and Forecast
6.3 Europe
6.3.1 Current Trend and Analysis
6.3.2 Market Size and Forecast
6.3.3 Germany
6.3.3.1 Market Size and Forecast
6.3.4 UK
6.3.4.1 Market Size and Forecast
6.3.5 France
6.3.5.1 Market Size and Forecast
6.3.6 Others
6.3.6.1 Market Size and Forecast
6.4 Asia-Pacific
6.4.1 Current Trend and Analysis
6.4.2 Market Size and Forecast
6.4.3 China
6.4.3.1 Market Size and Forecast
6.4.4 Japan
6.4.4.1 Market Size and Forecast
6.4.5 India
6.4.5.1 Market Size and Forecast
6.4.6 Others
6.4.6.1 Market Size and Forecast
6.5 RoW
6.5.1 Current Trend and Analysis
6.5.2 Market Size and Forecast
6.5.3 Middle East
6.5.3.1 Market Size and Forecast
6.5.4 South America
6.5.4.1 Market Size and Forecast
6.5.5 Africa
6.5.5.1 Market Size and Forecast
CHAPTER 7 COMPANY PROFILES
7.1 DePuy Synthes Companies
7.2 Cyberonics, Inc.
7.3 Nevro Corporation
7.4 St. Jude Medical, Inc.
7.5 BioControl Medical
7.6 Synapse Biomedical, Inc.
7.7 Neuropace, Inc.
7.8 Boston Scientific Corporation
7.9 NDI Medical, LLC
7.10 NeuroSigma, Inc.
1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 In-house Data Modeling
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OUTLINE
3.1 Market Inclination, Trend, Outlook and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Value Chain Analysis
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Impact Analysis
3.4.2 Restraints
3.4.2.1 Impact Analysis
3.4.3 Opportunities
3.5 Porter’s five forces analysis
3.5.1 Factors Impact Analysis
CHAPTER 4 NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE: MARKET SIZE AND FORECAST, 2015 – 2024
4.1 Overview
4.2 Implantable Devices
4.2.1 Current Trend and Analysis
4.2.2 Market Size and Forecast
4.2.3 Cochlear Implants
4.2.4 Deep Brain Stimulation
4.2.5 Spinal Cord Stimulation
4.2.6 Vagus Nerve Stimulation
4.2.7 Sacral Nerve Stimulation
4.2.8 Gastric Electric Stimulation
4.2.9 Others
4.3 External Devices
4.3.1 Current Trend and Analysis
4.3.2 Market Size and Forecast
4.3.3 Transcranial Magnetic Stimulation (TMS)
4.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
4.3.5 Others
CHAPTER 5 NEUROSTIMULATION DEVICES MARKET BY APPLICATION: MARKET SIZE AND FORECAST, 2015 – 2024
5.1 Overview
5.2 Parkinson’s Disease
5.2.1 Current Trend and Analysis
5.2.2 Market Size and Forecast
5.3 Pain Management
5.3.1 Current Trend and Analysis
5.3.2 Market Size and Forecast
5.4 Epilepsy
5.4.1 Current Trend and Analysis
5.4.2 Market Size and Forecast
5.5 Hearing Loss
5.5.1 Current Trend and Analysis
5.5.2 Market Size and Forecast
5.6 Gastroparesis
5.6.1 Current Trend and Analysis
5.6.2 Market Size and Forecast
5.7 Urinary and Fecal Incontinence
5.7.1 Current Trend and Analysis
5.7.2 Market Size and Forecast
5.8 Depression
5.8.1 Current Trend and Analysis
5.8.2 Market Size and Forecast
5.9 Others
5.9.1 Current Trend and Analysis
5.9.2 Market Size and Forecast
CHAPTER 6 NEUROSTIMULATION DEVICES MARKET BY GEOGRAPHY: MARKET SIZE AND FORECAST, 2015 – 2024
6.1 Overview
6.2 North America
6.2.1 Current Trend and Analysis
6.2.2 Market Size and Forecast
6.2.3 U.S.
6.2.3.1 Market Size and Forecast
6.2.4 Canada
6.2.4.1 Market Size and Forecast
6.2.5 Mexico
6.2.5.1 Market Size and Forecast
6.3 Europe
6.3.1 Current Trend and Analysis
6.3.2 Market Size and Forecast
6.3.3 Germany
6.3.3.1 Market Size and Forecast
6.3.4 UK
6.3.4.1 Market Size and Forecast
6.3.5 France
6.3.5.1 Market Size and Forecast
6.3.6 Others
6.3.6.1 Market Size and Forecast
6.4 Asia-Pacific
6.4.1 Current Trend and Analysis
6.4.2 Market Size and Forecast
6.4.3 China
6.4.3.1 Market Size and Forecast
6.4.4 Japan
6.4.4.1 Market Size and Forecast
6.4.5 India
6.4.5.1 Market Size and Forecast
6.4.6 Others
6.4.6.1 Market Size and Forecast
6.5 RoW
6.5.1 Current Trend and Analysis
6.5.2 Market Size and Forecast
6.5.3 Middle East
6.5.3.1 Market Size and Forecast
6.5.4 South America
6.5.4.1 Market Size and Forecast
6.5.5 Africa
6.5.5.1 Market Size and Forecast
CHAPTER 7 COMPANY PROFILES
7.1 DePuy Synthes Companies
7.2 Cyberonics, Inc.
7.3 Nevro Corporation
7.4 St. Jude Medical, Inc.
7.5 BioControl Medical
7.6 Synapse Biomedical, Inc.
7.7 Neuropace, Inc.
7.8 Boston Scientific Corporation
7.9 NDI Medical, LLC
7.10 NeuroSigma, Inc.
